These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 8413587

  • 1. Dopamine D4 receptors elevated in schizophrenia.
    Seeman P, Guan HC, Van Tol HH.
    Nature; 1993 Sep 30; 365(6445):441-5. PubMed ID: 8413587
    [Abstract] [Full Text] [Related]

  • 2. Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata.
    Seeman P, Guan HC, Van Tol HH, Niznik HB.
    Synapse; 1993 Aug 30; 14(4):247-53. PubMed ID: 8248849
    [Abstract] [Full Text] [Related]

  • 3. Dopamine D2-like sites in schizophrenia, but not in Alzheimer's, Huntington's, or control brains, for [3H]benzquinoline.
    Seeman P, Guan HC, Nobrega J, Jiwa D, Markstein R, Balk JH, Picetti R, Borrelli E, Van Tol HH.
    Synapse; 1997 Feb 30; 25(2):137-46. PubMed ID: 9021894
    [Abstract] [Full Text] [Related]

  • 4. Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression.
    Sumiyoshi T, Stockmeier CA, Overholser JC, Thompson PA, Meltzer HY.
    Brain Res; 1995 May 29; 681(1-2):109-16. PubMed ID: 7552267
    [Abstract] [Full Text] [Related]

  • 5. Are striatal dopamine D4 receptors increased in schizophrenia?
    Reynolds GP, Mason SL.
    J Neurochem; 1994 Oct 29; 63(4):1576-7. PubMed ID: 7931313
    [Abstract] [Full Text] [Related]

  • 6. Dopamine D4-like receptor elevation in schizophrenia: cloned D2 and D4 receptors cannot be discriminated by raclopride competition against [3H]nemonapride.
    Seeman P, Van Tol HH.
    J Neurochem; 1995 Mar 29; 64(3):1413-5. PubMed ID: 7861175
    [Abstract] [Full Text] [Related]

  • 7. Distribution of dopamine D1 and D2 receptors in rabbit cortical areas, hippocampus, and neostriatum in relation to dopamine contents.
    Dewar KM, Reader TA.
    Synapse; 1989 Mar 29; 4(4):378-86. PubMed ID: 2532424
    [Abstract] [Full Text] [Related]

  • 8. Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia.
    Murray AM, Hyde TM, Knable MB, Herman MM, Bigelow LB, Carter JM, Weinberger DR, Kleinman JE.
    J Neurosci; 1995 Mar 29; 15(3 Pt 2):2186-91. PubMed ID: 7891160
    [Abstract] [Full Text] [Related]

  • 9. Dopamine receptors and the dopamine hypothesis of schizophrenia.
    Seeman P.
    Synapse; 1987 Mar 29; 1(2):133-52. PubMed ID: 2905529
    [Abstract] [Full Text] [Related]

  • 10. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain.
    Seeman P, Guan HC, Niznik HB.
    Synapse; 1989 Mar 29; 3(1):96-7. PubMed ID: 2521961
    [No Abstract] [Full Text] [Related]

  • 11. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia.
    Joyce JN, Lexow N, Bird E, Winokur A.
    Synapse; 1988 Mar 29; 2(5):546-57. PubMed ID: 2973147
    [Abstract] [Full Text] [Related]

  • 12. Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.
    Schetz JA, Chu A, Sibley DR.
    J Pharmacol Exp Ther; 1999 May 29; 289(2):956-64. PubMed ID: 10215675
    [Abstract] [Full Text] [Related]

  • 13. Dopamine receptor pharmacology.
    Seeman P, Van Tol HH.
    Curr Opin Neurol Neurosurg; 1993 Aug 29; 6(4):602-8. PubMed ID: 8104554
    [Abstract] [Full Text] [Related]

  • 14. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
    Seeman P, Niznik HB, Guan HC, Booth G, Ulpian C.
    Proc Natl Acad Sci U S A; 1989 Dec 29; 86(24):10156-60. PubMed ID: 2574862
    [Abstract] [Full Text] [Related]

  • 15. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V, Rivet JM, Schreiber R, Dekeyne A, Spedding M, Nicolas JP, Peglion JL.
    J Pharmacol Exp Ther; 1998 Oct 29; 287(1):167-86. PubMed ID: 9765336
    [Abstract] [Full Text] [Related]

  • 16. Receptor-receptor link in membranes revealed by ligand competition: example for dopamine D1 and D2 receptors.
    Seeman P, Sunahara RK, Niznik HB.
    Synapse; 1994 May 29; 17(1):62-4. PubMed ID: 8042146
    [Abstract] [Full Text] [Related]

  • 17. Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epidepride.
    Seeman P, Guan HC, Van Tol HH.
    Eur J Pharmacol; 1995 Nov 14; 286(2):R3-5. PubMed ID: 8605946
    [Abstract] [Full Text] [Related]

  • 18. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
    Kang SG, Lee HJ, Choi JE, Park YM, Park JH, Han C, Kim YK, Kim SH, Lee MS, Joe SH, Jung IK, Kim L.
    Neuropsychobiology; 2008 Nov 14; 57(1-2):49-54. PubMed ID: 18451638
    [Abstract] [Full Text] [Related]

  • 19. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
    Galineau L, Wilson AA, Garcia A, Houle S, Kapur S, Ginovart N.
    Synapse; 2006 Aug 14; 60(2):172-83. PubMed ID: 16715499
    [Abstract] [Full Text] [Related]

  • 20. Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography.
    Seeman P, Tallerico T, Ko F.
    Synapse; 2003 Sep 15; 49(4):209-15. PubMed ID: 12827639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.